BMD screening of low risk patients for osteoporosis that was previously allowed
annually will be limited to once in any 24-month period, based on current scientific
evidence. For services on or after October 1, 1999, the 24-month period is determined from
April 1, 1998 onwards. The diagnostic facility should verify eligibility for insured BMD
testing with both the patient and the referring physician prior to rendering the service.
Additional BMD tests of low risk patients beyond the annual limit are uninsured.
High-risk patients will continue to receive unrestricted access to medically necessary
testing to assess fracture risk and monitor treatment. The relative value of technical
fees for BMD will be adjusted by 35% to reflect the lower cost of the new technology.
Enclosed is a Patient Fact Sheet that explains the above changes regarding BMD
benefits. This Fact Sheet may be reproduced by physicians for distribution to their